3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
15
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Surveys and Questionnaires
40
Blood Specimen Collection
30
Radiotherapy
20
Immunohistochemistry
13
Gene Expression Profiling
12
Radiotherapy, Intensity-Modulated
11
Cisplatin
11
Surgical Procedures, Operative
10
Biopsy
10
Drug Therapy
9
Cetuximab
9
Ultrasonography
8
Thyroidectomy
8
Observation
8
Transurethral Resection of Prostate
7
Nivolumab
7
Interviews as Topic
7
pembrolizumab
6
Therapeutics
6
Radiation
6
Polymerase Chain Reaction
6
Immunotherapy
6
Biopsy, Fine-Needle
6
Positron Emission Tomography Computed Tomography
5
Microarray Analysis
5
Liquid Biopsy
5
Iodine-131
5
Docetaxel
5
Chemoradiotherapy
5
Tissue Banks
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
trastuzumab deruxtecan
×
Head & Neck
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled